A pilot randomized controlled clinical trial to improve antiepileptic drug adherence in young children with epilepsy
Avani C Modi1, Shanna M Guilfoyle1, Krista A Mann1
1Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, U.S.A.
Insights
A family problem-solving intervention improved antiepileptic drug (AED) adherence in children with new-onset epilepsy. The Supporting Treatment Adherence Regimens (STAR) program showed significant benefits over standard care.
Area of Science:
- Pediatric Neurology
- Behavioral Science
Background:
- Pediatric epilepsy requires consistent antiepileptic drug (AED) adherence for effective management.
- Poor adherence to AEDs in children with epilepsy can lead to treatment failure and adverse outcomes.
- Family-centered interventions are crucial for supporting adherence in pediatric chronic conditions.
Purpose of the Study:
- To evaluate the preliminary efficacy of a family-tailored problem-solving intervention (STAR) for improving AED adherence in children with new-onset epilepsy.
- To assess the intervention's impact on adherence mechanisms, feasibility, and acceptability.
- To compare the STAR intervention with Treatment as Usual (TAU).
Main Methods:
- Fifty families of children with new-onset epilepsy completed baseline assessments and electronic monitoring for AED adherence.
- Families with adherence ≤95% were randomized to STAR (problem-solving sessions) or TAU.
- The STAR intervention comprised 4 face-to-face and 2 telephone problem-solving sessions over 8 weeks.
Main Results:
- Children receiving the STAR intervention showed significantly improved AED adherence compared to the TAU group during active treatment (weeks 4-8).
- The STAR group demonstrated significant improvements in epilepsy knowledge and management.
- Families reported positive experiences and benefits from the STAR intervention.
Conclusions:
- The STAR family problem-solving intervention shows preliminary efficacy in enhancing AED adherence for pediatric epilepsy.
- The intervention is feasible and acceptable to families, with positive impacts on knowledge and management.
- Future research should focus on larger samples and booster sessions to sustain adherence improvements.
Abstract:
The primary aim was to examine the preliminary efficacy of a family tailored problem-solving intervention to improve antiepileptic drug (AED) adherence in families of children with new-onset epilepsy. Secondary aims were to assess changes in targeted mechanisms and treatment feasibility and acceptability. Fifty families (M(age) = 7.6 ± 3.0; 80% Caucasian; 42% idiopathic localization related) completed baseline questionnaires and were given an electronic monitor to observe daily AED adherence. If adherence was ≤ 95% in the first 7 months of the study, families were randomized (Supporting Treatment Adherence Regimens (STAR): n = 11; Treatment as Usual (TAU): n = 12). Twenty-one families were not randomized due to adherence being ≥95%. The STAR intervention included four face-to-face and two telephone problem-solving sessions over 8 weeks. Significant group differences in adherence were found during active intervention (weeks 4-6; TAU = -12.0 vs. STAR = 18.1, p < 0.01; and weeks session 6-8: TAU = -9.7 vs. STAR = 15.3, p < 0.05). Children who received the STAR intervention exhibited improved adherence compared to children in the TAU group during active treatment. Significant changes in epilepsy knowledge and management were noted for the STAR group. Families expressed benefitting from the STAR intervention. Future studies should include a larger sample size and booster intervention sessions to maintain treatment effects over time.
More Related Videos
07:20Author Spotlight: Repetitive Transcranial Magnetic Stimulation Combined with Movement Observation in Cerebral Palsy
Published on: August 9, 2024
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Related Concept Videos
Clinical Trials: Overview
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
